From Memios
Practical writing and video on living strong and active into your 90s. No hype, no supplements to sell. Just what the evidence supports and what it looks like on an ordinary Tuesday.
320 items
Clear filters
Clonidine lowers blood pressure and calms the noradrenaline surge that drives opioid withdrawal, and it reduces the core symptoms of ADHD.
2026-09-29 · 19 min read

Clopidogrel reduces heart attacks, strokes and cardiovascular deaths in people who already have arterial disease, and it increases bleeding.
2026-09-29 · 14 min read

This is one of the better-evidenced drugs in modern medicine for its cardiac and kidney uses, resting on large placebo-controlled outcome trials rather than surrogate markers.
2026-09-29 · 23 min read

In short-term trials, amphetamines reduce clinician-rated ADHD symptoms more than placebo in both children and adults, with large effects on average.
2026-09-29 · 13 min read

Diclofenac is among the most effective oral anti-inflammatory painkillers and among the most cardiovascularly risky.
2026-09-29 · 24 min read

In the REWIND trial (9,901 people, median 5.4 years) it reduced the combined rate of heart attack, stroke and cardiovascular death from 13.4% to 12.0%, a hazard ratio of 0.88, while all-cause mortality did not differ.
2026-09-29 · 15 min read

Well established. It blocks the reabsorption of the brain chemicals serotonin and norepinephrine.
2026-09-29 · 17 min read

The literature is clear on what ergocalciferol does to a blood test and much less flattering about what it does to outcomes.
2026-09-29 · 14 min read

Large reviews of the trials find escitalopram, like other antidepressants, beats placebo for depression, and it is among the better-tolerated ones in head-to-head trials.
2026-09-29 · 13 min read

The evidence supports it as effective contraception: in the pivotal study of one such product there were 5 on-treatment pregnancies in 3,565 cycles without backup contraception, a Pearl Index of 1.82.
2026-09-29 · 17 min read

The evidence that ezetimibe lowers LDL cholesterol is solid and the size of that effect is modest; the evidence that it prevents heart attacks and strokes is real but small and contested.
2026-09-29 · 20 min read

The literature supports fenofibrate as a triglyceride-lowering drug whose effect on hard cardiovascular outcomes is unsettled.
2026-09-29 · 17 min read

Well established. Fluoxetine blocks the reuptake of serotonin by nerve cells.
2026-09-29 · 13 min read

For asthma, a Cochrane review found fluticasone effective compared with placebo, even at low doses, with more thrush, sore throat and hoarseness.
2026-09-29 · 13 min read

Well established. The evidence differs by approved use.
2026-09-29 · 12 min read

The strongest evidence is in pregnancy: pooled randomised trials show folic acid around conception cuts neural tube defects by roughly two thirds, with no clear effect on other birth defects.
2026-09-29 · 18 min read

It removes excess fluid quickly and is a mainstay for congestion in heart failure, but most of the trial evidence is old, small and short.
2026-09-29 · 10 min read

Glipizide lowers blood glucose by making the pancreas release more insulin. Pooled trials show sulfonylureas as a class drop HbA1c by about 1.5 percentage points compared with placebo, which is a large glucose effect.
2026-09-29 · 21 min read

Well established. The evidence for the two parts is strong but different.
2026-09-29 · 20 min read

Hydrochlorothiazide lowers blood pressure, but the big outcome trial that made thiazides first-line, ALLHAT, used chlorthalidone, not hydrochlorothiazide.
2026-09-29 · 12 min read

The best evidence is a 2010 Cochrane review of five randomised trials in generalised anxiety disorder: hydroxyzine beat placebo.
2026-09-29 · 12 min read

The evidence is that insulin aspart does the same job as regular human insulin, slightly better on average and slightly faster, not that it is a different kind of treatment.
2026-09-29 · 16 min read

Well established. It lowers blood sugar.
2026-09-29 · 10 min read

The evidence is that latanoprost reliably lowers pressure inside the eye, and that in one placebo-controlled trial this slowed the loss of visual field in newly diagnosed open-angle glaucoma over two years.
2026-09-29 · 13 min read
0:00/0:00